Walden Biosciences Announces Participation in Citi’s 17th Annual BioPharma Conference
31. August 2022 07:00 ET
|
Walden Biosciences, Inc.
CAMBRIDGE, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...
Walden Biosciences Announces Presentation at Canaccord Genuity 42nd Annual Growth Conference
04. August 2022 07:00 ET
|
Walden Biosciences, Inc.
CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...